XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:      
Revenue $ 8,120,176 $ 7,741,386 $ 5,480,826
Costs and expenses:      
Direct costs (excluding depreciation and amortization) 5,719,949 5,527,045 3,972,612
Selling, general and administrative 768,559 778,753 585,330
Depreciation and amortization 585,950 569,513 314,987
Transaction and integration related (Note 6) 44,176 39,695 198,263
Restructuring (Note 19) 45,390 31,143 31,105
Total costs and expenses 7,164,024 6,946,149 5,102,297
Income from operations 956,152 795,237 378,529
Interest income 5,014 2,345 574
Interest expense (Note 13) (336,699) (229,731) (182,423)
Income before income tax expense 624,467 567,851 196,680
Income tax expense (Note 20) (11,749) (59,411) (41,334)
Income before share of losses from equity method investments 612,718 508,440 155,346
Share of losses from equity method investments (383) (3,136) (2,161)
Net income $ 612,335 $ 505,304 $ 153,185
Net income per ordinary share (Note 24):      
Basic (USD per share) $ 7.46 $ 6.20 $ 2.28
Diluted (USD per share) $ 7.40 $ 6.13 $ 2.25
Weighted average number of ordinary shares outstanding (Note 24):      
Basic (in shares) 82,101,813 81,532,320 67,110,186
Diluted (in shares) 82,717,640 82,468,363 68,068,311